| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.6B | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | $0.1B |
| Net Income | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.0B | $0.1B | $0.0B |
| EPS (Basic) | $4.88 | $4.67 | $4.43 | $4.37 | $3.91 | $0.94 | $1.29 | $0.51 |
| EPS (Diluted) | $4.87 | $4.66 | $4.42 | $4.36 | $3.90 | $0.94 | $1.28 | $0.51 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.4B | $5.1B | $4.5B | $4.0B | $3.2B | $2.7B | $2.5B | $2.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $1.9B | $1.8B | $1.9B | $2.1B | $1.6B | $1.5B | $1.3B | $1.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.5B | $3.3B | $2.6B | $2.0B | $1.6B | $1.3B | $1.2B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.6B | $-0.7B | $-0.6B | $-0.5B | $-0.5B | $-0.3B | $-0.4B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.1B | $0.3B | $0.3B | $0.2B | $0.3B | $0.1B | $0.2B | $0.1B |